Jpmorgan Chase & CO Electromed, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Electromed, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 34 shares of ELMD stock, worth $1,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 368
90.76%
Holding current value
$1,028
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ELMD
# of Institutions
55Shares Held
2.5MCall Options Held
4.2KPut Options Held
3.7K-
Vanguard Group Inc Valley Forge, PA367KShares$11.1 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN360KShares$10.9 Million0.46% of portfolio
-
Dimensional Fund Advisors LP Austin, TX278KShares$8.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA214KShares$6.48 Million0.01% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny135KShares$4.09 Million0.03% of portfolio
About Electromed, Inc.
- Ticker ELMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,492,200
- Market Cap $257M
- Description
- Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...